Wellington Partners Technology is a division of the company focused on investments in early- and growth-stage technology companies. As of 2019 this technology division of the company had invested € 640 million in 120 companies across Europe. WP Tech has offices in Munich, London and Zurich. This part of the company as of 2019 was not making new investments in technology companies and was focused on value creation.
Wellington Partners Life Sciences division invests in early- and growth-stage life science companies, mainly in Europe, in amounts from €2m up to €20m over the life of the investment. Their focus is in therapeutics, medtech, diagnostics, digital health and biotechnology. As of 2019 more than € 400 million of funds raised were dedicated to life sciences.
Biotech Tests Pig-to-Human Transplants With New Funds
The investment, led by Fresenius Medical Care Ventures, brings funding for eGenesis to $138 million, with participation from new investors including Bayer AG’s investment arm, Leaps by Bayer, and Wellington Partners.
Stephan von Perger
Documentaries, videos and podcasts